A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells (2022)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; PARISE FILHO, ROBERTO - FCF ; MACHADO NETO, JOÃO AGOSTINHO - ICB
- Unidades: ICB; FCF
- DOI: 10.1016/j.htct.2022.09.267
- Subjects: INIBIDORES DE ENZIMAS; APOPTOSE; LEUCEMIA MIELOIDE AGUDA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1379
- Volume/Número/Paginação/Ano: v. 44, Supl. 2, p. s158-s159, 2022
- Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO)
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
JAEG, Carlos et al. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2022.09.267. Acesso em: 30 set. 2024. , 2022 -
APA
Jaeg, C., Almeida, L. C., Lima, K., Tavares, M. T., Waitman, K. B., Costa-Lotufo, L. V., et al. (2022). A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.htct.2022.09.267 -
NLM
Jaeg C, Almeida LC, Lima K, Tavares MT, Waitman KB, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s158-s159.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.htct.2022.09.267 -
Vancouver
Jaeg C, Almeida LC, Lima K, Tavares MT, Waitman KB, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s158-s159.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.htct.2022.09.267 - Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models
- DNA damaging agents and DNA repair: from carcinogenesis to cancer therapy
- Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models
- Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment
- BIRC5 (baculoviral IAP repeat containing 5)
- AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis
- BIRC8 (baculoviral IAP repeat containing 8)
- Potential candidates for new anticancer agents: synthesis and evaluation of antitumor activity of tioureidics and ureidics analogs of capsaicin
- Planejamento e síntese de análogos bioisostéricos da capsaicina com potencial atividade antitumoral
- Design and synthesis of capsaicin-like sulfonamide analogues as potential antitumor agents
Informações sobre o DOI: 10.1016/j.htct.2022.09.267 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
